With GPx, doctors can monitor their patients’ blood biomarkers remotely - without needles or implants
GPx’s first product, CardioID, provides doctors with continuous and actionable remote monitoring of NT-proBNP for heart failure (HF) patients.
GPx’s predictive algorithms are trained on our proprietary real-world digital and blood biomarker database. We call these algorithms Bloodless Blood Tests.
function init() { clock = new THREE.Clock() ; camera = new THREE.Camera(); uniforms = { u_resolution:{ type:"v2",value: new THREE.Vector2() }, u_progress :{ }, uMouse: { value: {x: 0.5, y: 0.5} }, };
function init() { clock = new THREE.Clock() ; camera = new THREE.Camera(); uniforms = { u_resolution: { type:"v2",value:new ...
GPx’s predictive algorithms are trained on our proprietary real-world digital and blood biomarker database. We call these algorithms Bloodless Blood Tests.
GPx is actively looking for partners for the largest study of Bloodless Blood Test technology with heart failure patients. If you are interested in learning more, please contact us.
#STRONGHF results from high-intensity #heartfailure therapies + #NTproBNP monitoring were so positive that the stud… https://t.co/nZ302QBmr4
RT @ExTechChallenge: We received hundreds of applications, full of inspiring tech innovations, from over 40 countries for the XTC Startup C…
RT @stacyamityfeld: Congratulations to all of the startups that pitched at the #HLTH2022 Startup Pitch Competition and to @OpticSurg and Ge…
About the company
GPx is focused on improving the lives of individuals with chronic disease via personalized and predictive innovations that are easy for patients to live with and help clinicians deliver the best care.
contact@gpx.ai
cs@gpx.ai
479-4357